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Dr Lichtdoi:10.1016/j.jtcvs.2004.07.022Objective: Impaired neurodevelopmental outcome represents a major morbidity for
survivors of infant heart surgery for congenital heart defects. Previous studies in
these neonates have reported preoperative microcephaly, periventricular leukoma-
lacia, and other findings. The hypothesis of this study is that preoperative cerebral blood
flow is substantially diminished and might relate to preoperative neurologic conditions.
Methods: Preoperative brain magnetic resonance imaging was performed. Cerebral
blood flow measurements in infants with congenital heart defects were obtained by
using a novel noninvasive magnetic resonance imaging technique, pulsed arterial
spin-label perfusion magnetic resonance imaging. Cerebral blood flow was mea-
sured before the operation under standard ventilation and repeated after increased
carbon dioxide.
Results: A total of 25 term infants were studied. The average age at the time of
the operation was 4.4  4.6 days. Congenital heart defects varied widely.
Microcephaly occurred in 24% (6/25). Baseline cerebral blood flow was 19.7 
9.2 mL · 100 g1 · min1 (8.0-42.2 mL · 100 g1 · min1). Five patients had
cerebral blood flow measurements of less than 10 mL · 100 g1 · min1. Mean
hypercarbic cerebral blood flow increased to 40.1  20.3 mL · 100 g1 · min1
(11.4-94.0 mL · 100 g1 · min1, P  .001). Pairwise analyses found that low
hemoglobin levels were associated with higher baseline cerebral blood flow
values (P  .04). Periventricular leukomalacia occurred in 28% (7/25) and was
associated with decreased baseline cerebral blood flow values (P  .05) and a
smaller change in cerebral blood flow with hypercarbia (P  .003).
Conclusions: Structural brain abnormalities are common in these neonates before
surgical intervention. Preoperative cerebral blood flow for this cohort was low
and drastically reduced in some patients. Low cerebral blood flow values were
associated with periventricular leukomalacia. Carbon dioxide reactivity was
preserved but might be compromised by some aspects of the cardiac anatomy.
The full spectrum of cerebral blood flow measurements with this technique in
congenital heart defects and their long-term significance require continued investigation.
Approximately 30,000 infants are born with congenital heart de-fects (CHD) in the United States each year. A third of theseinfants will have severe and complex cardiac lesions that willrequire surgical repair in the first few months of life. Increasedsurvival after neonatal cardiac surgery has since shifted physi-cians’ attention to preventing neurologic injury and improving
neurocognitive outcome in these high-risk patients.1-5 Studies of preoperative risk
factors in this patient population are extremely limited.
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DMahle and colleagues6 performed preoperative and post-
operative brain magnetic resonance imaging (MRI) exami-
nations and MRI spectroscopy in infants with complex
CHDs and found preoperative periventricular leukomalacia
(PVL) in 4 (17%) of 24 infants. Furthermore, 10 (53%) of
19 infants who underwent preoperative spectroscopy
showed increased white matter lactate levels, suggesting
tissue ischemia. The proportion of patients with PVL deter-
mined on the basis of postoperative MRI increases to more
than 50%.7 Reported autopsy findings in 39 neonates with
hypoplastic left heart syndrome showed a high occurrence
of microencephaly (low brain weight) and open opercula, a
minor form of cortical underdevelopment, which suggest
chronic cerebral underperfusion.8,9
PVL principally arises from injury to immature oligoden-
drocytes, which are particularly prone to ischemia10 in cerebral
watershed areas.11 In preterm infants PVL is highly associated
with long-term neurodevelopmental consequences, but the sig-
nificance of PVL in term infants with CHD remains under
investigation. Nevertheless, the occurrence of neurodevelop-
mental sequelae after infant heart surgery is well established.
In prospective cohort studies of cognitive outcome after the
Fontan procedure, it has been observed that 8% to 15% of
survivors had full-scale IQs of less than 70.3,4
Because a significant proportion of neonates with CHD
have PVL, microcephaly, or underdeveloped opercula be-
fore heart surgery, their presence requires an examination of
preoperative factors, such as cerebral blood flow (CBF), that
might be related to short-term and long-term central nervous
system (CNS) consequences. To our knowledge, quantita-
tive measurements of CBF exclusively in neonates with
CHDs before surgical intervention have never been pub-
lished. These findings might greatly contribute to our un-
derstanding of cerebral injury and might suggest future
neuroprotective strategies. This investigation uses pulsed
arterial spin-labeling perfusion magnetic resonance imaging
(PASL-pMRI) to quantify preoperative CBF. This novel
imaging technique uses electromagnetically spin-labeled ar-
terial blood water as a noninvasive diffusible tracer to
measure CBF flow in standard physiologic units in millili-
ters per 100 grams per minute.12
The major aims of this study are (1) to investigate the
evidence of preoperative CNS anatomic abnormalities, in-
cluding PVL, in neonates with complex CHDs; (2) to mea-
sure preoperative CBF by using PASL-pMRI to test the
hypothesis that CBF is low and might be associated with
observed anatomic CNS abnormalities; and (3) to measure
cerebral vascular responsiveness to inspired CO2, a known
cerebral vasodilator. This is of interest because impaired
CO2 reactivity has been associated with poor neurodevel-
opmental outcome and a higher risk of death in all age
groups.13-15
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Patient Population
With institutional review board approval, all newborn infants with
CHDs admitted to the cardiac intensive care unit at The Children’s
Hospital of Philadelphia were evaluated for study inclusion. In-
clusion criteria included full-term age (gestational age, 40  4
weeks), an intention to undergo surgical intervention with cardio-
pulmonary bypass with or without deep hypothermic circulatory
arrest (DHCA), and medical stability for 24 hours before the
operation. Infants were excluded if they had a history of birth
asphyxia (5-minute Apgar score of 5 or cord pH of 7.0) or a
preoperative cardiac arrest requiring chest compressions. Patients
with hypoplastic left heart syndrome treated with hypercarbia for
pulmonary overcirculation were also excluded.
CHD Anatomies
A wide variety of specific CHDs were studied (Table 1). Lesions
were further anatomically classified into one of 4 categories, as
described by Clancy and associates16: additional descriptors, such
as an obstructed aortic arch, patent ductus arteriosus, or single-
ventricle physiology, were included to assess associations with
CBF and CO2 reactivity.
MRI and Perfusion Sequences
All MRI scans were performed on Siemens Vision or Sonata 1.5T
scanners. The full technical details of the imaging and perfusion
studies are available elsewhere.12 The pulsed arterial spin-labeled
MRI sequence (PASL-pMRI) was a modification of a previously
described technique.17 PASL-pMRI has been compared with gad-
olinium bolus perfusion MRI in cases of adult stroke18 and has
been validated in adults against H215O positron emission tomog-
raphy.19 Three PASL-pMRI scans were carried out immediately
before the operation under standard ventilator settings, followed by
2 PASL-pMRI scans after increased CO2.
The structural scans included sagittal T1-weighted turbo-spin
echocardiography and axial T1, T2, and fluid attenuation inversion
recovery sequences. Structural image interpretation was performed
by a single neuroradiologist (RAZ), who was blinded to the pa-
tient’s clinical condition and diagnosis. MRI scans were reviewed
for congenital abnormalities and acquired abnormalities, such as
PVL, which was graded on a 4-point scale from absent to mild,
moderate, or severe. Closure of the operculum was rated as com-
plete or incomplete.
Ventilation and Patient Monitoring
All patients had indwelling umbilical or peripheral arterial and
venous catheters that were not dictated by study participation. All
patients were mechanically ventilated and stabilized with a base-
line goal PaCO2 of 40 mm Hg confirmed by means of arterial blood
gas analysis before the first CBF measurement. Hypercarbic gas
mixture was administered and adjusted to a goal inspired fraction
of CO2 (FiCO2) of 20 mm Hg (equivalent to an FiCO2 of 2.7%).
Vital signs and pulse oximetry were monitored continuously.
Prostaglandin infusions were discontinued 1 hour before study
initiation. Patients were medicated with fentanyl (5 g/kg) and
pancuronium (0.2 mg/kg). None received inotropes during the
study or boluses of calcium, bicarbonate, or volume expanders.
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Study patients were transported by the cardiac anesthesia team from
the cardiac intensive care unit to the operating room for induction of
anesthesia, endotracheal intubation, and establishment of vascular
access 1 hour before the scheduled operation. Patients were then
transported to the MRI suite. Initial arterial and venous blood samples
were drawn for baseline PaCO2 measurement. On completion of the
first perfusion MRI sequence, supplemental CO2 was administered to
achieve a goal FiCO2 of 20 mm Hg. Sequences for structural MRIs
were obtained during CO2 equilibration. A second pMRI sequence
was then performed to measure CBF in the hypercarbic state. Finally,
a second set of blood gas samples was obtained to confirm the higher
PaCO2 level. The hypercarbic gas mixture was then discontinued, and
the patient was transported directly to the operating room. The aver-
age study duration was 83  6 minutes.
Statistical Analysis
Patient and MRI data were characterized by simple descriptive
statistics, including mean, SD, median, and range values. Outcome
end points were associated with other variables that could be
plausibly considered as predictors in a pairwise fashion. For con-
tinuous scale predictors, the Pearson and Spearman correlations
were examined. Generalized linear models based on many predic-
tor variables were also explored. Because of the limited sample
TABLE 1. Patient demographics and cardiac diagnoses
Patient demographics N
Cohort size 25
Sex
Male 13
Female 12
Race
African American 3
White 17
Hispanic 4
Other 1
Cardiac diagnosis
Aortic stenosis 1
Heterotaxy 1
HLHS 7
HLHS variant 2
Single ventricle: other 2
PA/IVS 1
TAPVR 1
TGA/IVS 2
TGA/VSD 2
TGA/VSD/coarct 1
TOF 1
TOF/PA 1
Truncus arteriosus 1
VSD/coarct 2
HLHS, Hypoplastic left heart syndrome; PA, pulmonary atresia; IVS, intact
ventricular septum; TAPVR, total anomalous pulmonary venous return;
TGA, transposition of the great arteries; VSD, ventricular septal defect;
coart, coarctation of the aorta; TOF, tetralogy of Fallot.size, not every candidate predictor could be included in every
The Journal of Thoracimodel. Stepwise selection procedures were conducted to identify
strong predictors, which also removed weaker predictors from the
model. The stepwise procedure tends to find models that are better
than any pairwise model but also more parsimonious than the full
model. Finally, some models were examined with interaction
terms on the basis of the stepwise models, which shows how one
predictor might modify the effect of another.
Results
Patient Demographics
The parents of 28 patients were approached for enrollment
in this study: of these, 3 declined consent. Of the 25 patients
studied, 2 lost CBF data because of a technical difficulty
with the MRI. These 2 patients were included for all other
analyses of data, including safety analysis and structural
MRI data analysis. Tables 1 and 2 describe cardiac diag-
noses and patient characteristics, respectively. The cardiac
diagnoses were made on the basis of prenatal fetal echocar-
diography in 13 (52%), at the time of birth in 11 (44%), and
as an outpatient in 1 (4%).
Hemodynamic and Blood Gas Data
Table 3 shows the baseline and hypercarbic vital signs,
including transcutaneous oxygen saturation, heart rate, and
systolic, diastolic, and mean arterial blood pressures. There
were no statistically significant changes in vital signs with
TABLE 2. Patient demographics
Average Range
Gestational age (wk) 38.7 1.2 36-40
Day of life (d) 4.7 4.9 1-26
Head circumference (cm) 33.3 1.2 30.5-30.3
Birth weight (kg) 3.1 0.42 2.5-4
TABLE 3. Vital signs and blood gas measurements for both
baseline and hypercapnic conditions
Baseline (n  25) Hypercapnic (n  25) P value*
HR 138.4 17.3 141.8 17.7 .09
MAP 55.4 10.7 56.8 9.1 .75
FiCO2 0  0.0 23.5  4.5 .01
Hb 14.6  1.8 14.6 1.9 .9
pH 7.38  0.06 7.23 0.06 .01
PaCO2 40.7 5.4 61.6  7.0 .01
PaO2 43.7 12.6 52.8 12.4 .0002
SaO2 74.2 14.0 74.5 14.0 .9
CaO2 14.6 3.3 14.7  3.1 .9
HR, Heart rate; MAP, mean arterial pressure; FiCO2, fraction of inspired
carbon dioxide; Hb, hemoglobin concentration; PaCO2, arterial partial pres-
sure of carbon dioxide; PaO2, arterial partial pressure of oxygen; SaO2,
arterial oxygen saturation; CaO2, arterial oxygen content.the administration of CO2 through the ventilator.
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Table 4 illustrates the absolute CBF values for the cohort
expressed in milliliters per 100 grams per minute at baseline
and during hypercarbic conditions, as well as CO2 reactiv-
ity, defined as the change in CBF divided by the change in
pCO2. Individual changes in CBF are shown in Figures 1 and
2. Baseline CBF was inversely and linearly associated with
hemoglobin concentration (P  .04). There was no signif-
icant association between baseline CBF and heart defect,
regardless of their classification. CO2 reactivity for the
group was 0.96  0.61 mL · 100 g1 · min1 · mm Hg1
change in pCO2. CO2 reactivity was correlated with diastolic
blood pressure (BP) and inversely correlated with hemoglo-
bin concentration (Hb) and PVL (P  .001, .02, and .02,
respectively). CO2 reactivity could be predicted by using the
following linear regression: CO2 reactivity  4.1  0.14
Figure 1. Individual baseline CBF. Black andwhite bars
heavy horizontal line indicates the average CBF for th
TABLE 4. Average CBF measurements in patients with an
Baseline CBF (mL/100 g per min)
Total no. of patients 24
All patients 19.73 9.15
Presence of PVL
Patients with PVL (n  7) 13.86 5.39
Patients without PVL (n  17) 22.14 9.67
P  .05
CBF, Cerebral blood flow; PVL, periventricular leukomalacia.(Diastolic BP)  0.24 (If PVL)  0.2 (Hb).
844 The Journal of Thoracic and Cardiovascular Surgery ● DeceClassifying the CHD by using the methods described by
Clancy and associates16 failed to resolve differences in CO2
reactivity. The presence of either aortic arch obstruction or
single-ventricle physiology showed marked decreased reac-
tivity; however, wide SDs kept them from reaching signif-
icance (P  .14 and P  .18, respectively).
Structural MRI Data
Thirteen (53%) patients had evidence of developmental le-
sions, acquired lesions, or both, including microcephaly, in-
complete closure of the operculum, PVL, and other ischemic
lesions. PVL was detected in 7 (28%) patients and was mod-
erate to severe in 3 (12%) patients. Significantly, the presence
of PVL was associated with low baseline CBF values (P 
.05) and decreased CO2 reactivity (P  .02, Table 4). The
average head circumference was significantly lower than that
esent patients with and without PVL, respectively. The
hort.
thout PVL
percapnic CBF (mL/100 g per minute) CO2 reactivity (CBF/pCO2)
23 23
40.13 20.31 0.903 0.546
28.72 16.21 0.633 0.326
45.12 20.98 1.02 0.604
P  .003 P  .02reprd wi
Hyof the normal population without heart defects (P  .0001).
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DMicrocephaly, defined as more than 2 SDs less than the normal
mean, was seen in 6 (24%) of 25 patients. Incomplete closure
of the operculum was identified in 4 (16%) of 25 patients. An
association between these 2 structural abnormalities, baseline
CBF and CO2 reactivity, failed to reach statistical significance.
Discussion
Although there has been wide appreciation of the long-term
neurocognitive consequences of neonatal heart surgery, the
main focus of attention has been directed to specific intra-
operative risk factors, including DHCA, hemodilution, and
acid-base management. However, there is a growing body
of evidence that suggests that preoperative features might
also influence short-term and long-term outcome. The oc-
currence of preoperative microcephaly, PVL, increased
white matter lactate, and the persistence of open opercula
raise the concern for chronic cerebral hypoperfusion that
might adversely affect the brain long before the conduct of
surgical intervention. Specific data on CBF in this popula-
tion are extremely scarce, and methods for measurement are
troublesome. Color Doppler imaging is noninvasive and
portable but measures only blood flow velocity, and results
are dependent on probe angulation. Near-infrared spectros-
copy is also portable and noninvasive but measures changes
in cerebral oximetry (not CBF) in only a small area of the
Figure 2. Individual CBF at baseline and with hyperc
lines denote patients who did not have PVL. Open circortex. Again, probe placement is crucial. This is the first
The Journal of Thoracistudy using PASL-pMRI to measure global CBF in neo-
nates with severe forms of CHD and to relate these values
to observed anatomic abnormalities.
As previously reported in other CHD populations, this
study cohort demonstrated several preoperative anatomic ab-
normalities.6,8,9 The most common was PVL, observed in 28%
of the study group. The mean head circumference was signif-
icantly less than the norm for term neonates. Microcephaly, an
indicator of decreased brain growth and an important marker
for adverse neurodevelopment, was the second most common
structural brain abnormality and observed in 24% of the study
group. Delayed closure of the opercula occurred in 16% of the
patients. Remarkably, more than 50% of the study cohort had
one or more of these CNS findings that could be attributed to
chronic cerebral hypoperfusion.
Prior studies of CBF in pediatric CHD used 133Xe clearance
methodology and recorded the effects of hypothermia, cardio-
pulmonary bypass, and DHCA on CBF and cerebral metabo-
lism.20-23 These studies, which included prebypass conditions,
examined a broad range of ages that included neonates. In our
cohort, CBF values were measured and regarded as specific
risk factors for the observed preoperative structural brain ab-
normalities. The mean CBF value for the cohort was 19.7 
9.1 mL · 100 g1 · min1, which was much lower than the
normal value of 50  3.4 mL · 100 g1 · min1 reported by
conditions. Solid squares connected by solid black
connected by broken lines denote patients with PVL.apnicChiron and coworkers24 in term infants under conditions of
c and Cardiovascular Surgery ● Volume 128, Number 6 845
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Dconscious sedation. Significantly, 5 neonates had CBF values
of less than 10 mL · 100 g1 · min1, the level generally
recognized to cause moderate ischemic changes in piglets.25
Baseline CBF values varied linearly and inversely with hemo-
globin concentration. Likewise, CO2 reactivity was modeled as
a function of hemoglobin concentration and diastolic blood
pressure. These associations occur in all age groups and in
different species. The observed low CBF measurements were
also congruent with the study of Greeley and associates,20-22
which included neonates, although specific neonatal CBF val-
ues were not detailed. Markedly low CBF measurements (10
mL · 100 g1 · min1) have been made in other studies
examining critically ill neonates with normal short-term out-
comes.26
These low CBF measurements are also consistent with
prior reports of preoperative increased white matter lactate
levels,6 indicating a preischemic state. In this study all 3
infants with moderate-to-severe PVL had CBF values of
less than 10 mL · 100 g1 · min1. It should be noted that
although a significant association between low CBF and
PVL was demonstrated, a true causal effect was not. Brain
metabolism was not concurrently measured; therefore it is
not possible to determine whether the low CBF values
represented an appropriate response to low cerebral metab-
olism from a white matter ischemic state.
CO2 reactivity for the cohort averaged 0.96  0.61 mL ·
100 g1 · min1 · mm Hg1, with a wide range from 0.22 to
2.17 mL · 100 g1 · min1 · mm Hg1. In previous pediatric
studies CO2 reactivity of greater than 2 mL · 100 g1 · min1
· mm Hg1 was associated with survival, whereas reactivity of
less than 1.0 mL · 100 g1 · min1 · mm Hg1 was associated
with death or poor neurologic outcome.14,15 In this limited
cohort, the broad range of reactivity values and heterogeneous
patient population precluded detailed predictor analyses, al-
though the presence of aortic arch obstruction and single-
ventricle physiology trended toward an association with re-
duced CO2 reactivity. The wide range of CO2 reactivity values
obtained were similar to those measured with 133Xe SPECT in
infants undergoing venoarterial extracorporeal membrane ox-
ygenation.26
PASL-pMRI is a noninvasive technique to measure CBF
directly by using electromagnetically labeled arterial blood
water as an endogenous tracer. Over the past decade, method-
ologies for PASL-pMRI have evolved from feasibility studies
into practical use12,27 and are now being used in pediatric
populations.17 Our prior studies demonstrated a substantial
improvement in the signal-to-noise ratio of perfusion images in
neurologically healthy children compared with healthy
adults,17 and CBF values were comparable with those obtained
by using radioactive measurement techniques.24 Moreover, a
high reproducibility of 5.3% (6.2 mL · 100 g1 · min1) at the
95% confidence interval was observed for the 2 repeated
perfusion scans after CO2 administration. The accuracy of
846 The Journal of Thoracic and Cardiovascular Surgery ● DecePASL measurements in the presence of drastically reduced
CBF and slow blood flow requires further evaluation.
The absence of a control group is a major limitation of
this study. In light of this limitation, neonates without CHD
might undergo CBF determination with PASL-pMRI, but it
is acknowledged that these studies will not be acquired
under identical conditions as in the neonates with CHDs.
We demonstrate that preoperative structural brain abnor-
malities were seen in more than 50% of the cohort, with the
most common being PVL (28%) and microcephaly (24%).
CBF in these neonates was measured safely and noninva-
sively with PASL-pMRI. Observed CBF values were much
lower than what is suggested by limited normal data and
critically decreased in some patients. The presence of PVL
was strongly associated with low baseline CBF and poor
CO2 reactivity.
There continue to be important gaps in our knowledge
concerning the pathogenesis of adverse neurodevelopment in
infants with severe CHD. These data draw attention to the
potential role of low CBF being an underrecognized preoper-
ative risk factor for poor neurocognitive outcome. The obser-
vation in which hypercarbia increases CBF to near-normal
levels provides hope that this or other potential agents might be
exploited in future neuroprotection strategies.
We thank Dr R. Ichord, Mr Dongbo Hu, Ms Christine Harris,
Mr Ralph Magee, and Mr Erin O’Tool for their cooperation,
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Discussion
Dr Erle H. Austin III (Louisville, Ky). I would like to congratulate
you on a clear presentation of new and important information that
characterizes the neurologic condition of infants with severe CHDs
when it is evaluated before they are subjected to the significant
perturbations of bypass with or without DHCA.
I would also like to thank you for your involvement in this area.
It is pediatric neurologists such as you that can help us identify the
best ways to mitigate the adverse neurologic outcomes that con-
tinue to occur despite remarkable improvements in operative sur-
vival for infants with complex forms of congenital heart disease.
The Journal of ThoraciYour study, I think, is of value because it confirms a previously
described high incidence of structural cerebral lesions in this group
of patients. The most common lesion that you noted was PVL.
The major point of the work, however, relates to the low level
of preoperative CBF that you have demonstrated with your tech-
nique of spin-label perfusion MRI. It is not difficult for us to accept
this low level of CBF as a significant factor that might compromise
the infant preoperatively and possibly make him or her more
susceptible to additional neurologic injury with the operative pro-
cedure.
My major concern with the study is the use of a new technique
for measuring CBF that does not appear to have been adequately
compared with a more traditional technique, such as xenon wash-
out. I recognize that such a comparison is not easy in newborn
infants, but I am curious as to what studies have been done to
validate this technique in an animal model or possibly clinical
comparisons with transcranial Doppler scanning or other clinical
measurement tools.
In addition, the values of CBF that you have shown are com-
pared with normal values that are derived from a completely
different technique of measuring CBF.
This brings me to my first question.
Would you comment on the validity of spin-label perfusion
MRI for accurately measuring CBF and how it has been compared
with a gold standard. Also, could you comment on the absence of
control data from a group of neonates without congenital heart
disease.
Dr Licht. Thank you for your kind words.
Arterial spin labeling has been used for years in the adult stroke
population and in functional MRI testing. It has been validated against
015 positron emission tomography scans in adults in blood flow
ranges between 20 and 80 mL · 100 g1 · min1. A direct comparison
with xenon-133 SPECT, however, has not been done.
Animal studies have been done in rats and larger mammals.
That work was pioneered by John Detre, who is a coauthor of this
article.
In functional MRI, PASL-pMRI has been directly compared
with the blood oxygen level–dependent technique; however, the
results of arterial spin labeling are more reproducible and stable
over serial measurements. If regional CBF is measured during the
performance of simple motor tasks in adult patients and then
remeasured hours, days, or weeks later, the same values are ob-
tained. The reproducibility of the results is very good.
The arterial spin-labeling measurements are also internally
consistent: patients with the lowest CBF measurements have the
highest risk for demonstrating PVL, presumably an ischemic in-
jury. The reproducibility of our results has also been demonstrated
by performing test-retest experiments under hypercarbic condi-
tions. The reproducibility of our measurements (9%) exceeded
standard expectations (10% error).
Dr Austin. How about using this in a set of control infants with
that congenital heart disease? Do you want to comment about that?
Dr Licht. We have studied older children with arterial spin
labeling to measure the developmental changes that take place in
childhood. Our CBF values are essentially the same as those
reported by Chiron and coworkers in their series in 1992.
We have not measured neonates without CHD at this point. Our
hospital only has our born neonates, and therefore these are not
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Dtrue normal control subjects. It is possible to study CBF with
PASL-pMRI in infants without CHD who are receiving an MRI of
the brain for other clinical indications. One must also keep in mind
that we will never be able to study healthy neonates under the same
study conditions (ie, intubated, paralyzed, and sedated).
Dr Austin. So what were the flow values that you were just
referring to from Chiron and coworkers?
Dr Licht. Chiron and coworkers measured CBF in 42 children,
ages 2 days to 19 years. The measurements were made for clinical
neurologic indications that were retrospectively determined to be
transient and unaccompanied by structural brain lesions. The chil-
dren developed normally, and the SPECT measurements were
added to the database of normal values.
Dr Austin. But what value of flow was measured? What was
considered to be normal?
Dr Licht. The measurements were made in 7 neonates with a
natural airway. The average value in these 7 neonates, ages 2 to 45
days, was 50  3.4 mL · 100 g1 · min1.
Dr Austin. And clearly, in this group, these are significantly
lower. And I think it’s fair for us to assume that you’ve done a lot
to try and validate this. Again, I think it’s interesting and may be
important data.
A second question relates to, there were 5 patients with very
low preoperative cerebral blood flow measurements. Were there
any clinical signs of a neurologic impairment in those patients?
Dr Licht. No.
Dr Austin. And recognizing the limitations of neurologic ex-
aminations in newborn babies. But you are a neurologist.
Dr Licht. Yes, there is no predictive value to the neonatal
neurologic examination, and therefore neurologic examination was
not part of this protocol. But these babies were all similar in that
they had no prior history of birth asphyxia and no history of arrest
of any sort.
Dr Austin. Finally, have you, at least anecdotally, used this
technique postoperatively in any of the members of this cohort to
determine whether there is any effect of the surgical procedure?
Dr Licht. We have not. But that study is in planning, and we
should start recruitment in the next couple of weeks.
Christo I. Tchervenkov (Montreal, Quebec, Canada). I con-
gratulate you for working in an area that I think is becoming
increasingly important. It has been conventional wisdom to assign
neurologic injury to what happens in the operating room or,
perhaps, after the operating room. But we are beginning to recog-
nize that some of these injuries might actually happen before any
surgical insult.
A few years ago at the Montreal Children’s Hospital, we did
look at the neurologic status before surgical intervention in a series
of neonates and infants with various diagnoses. To our surprise,
60% of neonates and 40% of infants had some kind of neurologic
or developmental preoperative abnormalities. And in many of
these, the abnormality persisted after the operation. There were
very few new events.
And what was very interesting to see in that cohort of patients
was that there seemed to be a difference between the cyanotic
patients, such as transposition or tetralogy, and patients who had
significant left-to-right shunts, such as complete atrioventricular
canal, ventricular septal defect, hypoplastic left heart, and so on.
And the incidence of preoperative abnormalities was higher in the
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diagnoses there is decreased CBF prenatally.
Therefore my question is the following: Have you looked at
stratifying your cohort of patients when you are measuring CBF in
terms of cyanotic patients versus noncyanotic patients?
Dr Licht. That is an excellent suggestion. We have not spe-
cifically compared CBF values in cyanotic versus noncyanotic
groups. We have stratified the patients according to their clinical
heart diagnosis. We have also classified them according to the
method proposed by Clancy and colleagues in the risk-of-death
article, in which heart lesions were grouped into one of 4 classes:
single ventricle without arch obstruction, single ventricle with arch
obstruction, 2 ventricles without arch obstruction, and 2 ventricles
with arch obstruction. We also looked at the effect of the ductus
arteriosus. We compared patients with a patent ductus arteriosus
with those without, and determined whether the ductus was re-
quired for pulmonary circulation or systemic circulation. Thus far
in our analysis, we have failed to find a significant correlation of
CBF with any of the structural anatomic characteristics.
I will say that babies with a prenatal diagnosis of a CHD had
significantly lower CBF values than babies given diagnoses at or
after the time of birth. These babies did not differ significantly in
birth weight or head circumference. Furthermore, although most
babies with hypoplastic left heart syndrome were given diagnoses
prenatally and babies with transposition of the great arteries were
given diagnoses postnatally, the babies with transposition of the
great arteries had much lower CBF values than babies with hyp-
oplastic left heart syndrome. Whether this is a spurious result
remains to be seen after further evaluation.
Dr Marshall L. Jacobs (Philadelphia, Pa). This is a lovely
study, and you obviously found the issue of PVL sufficiently
significant to single it out with the yellow bars and highlight it in
multiple aspects of the analysis. Of course, the same group with, I
guess, Dr Gaynor as the author documented a certain frequency in
preoperative patients, some evolution, and some new findings of
PVL in postoperative patients. Could you share with the group
your insights as to what specifically is the significance of this
particular finding and how closely it correlates with inadequate
blood flow and hypoxic injury.
Dr Licht. The injury itself, PVL, is believed to arise from several
factors in premature babies. One major contributor is the immature
oligodendrocyte. In the developing brain these cells are highly met-
abolically active and are particularly vulnerable to hypoxic ischemic
injury. Another consideration is that the injury occurs in the watershed
region between the small arteries that penetrate from the cortex and
those that arise from the ventricle surface and run radially outward.
This watershed area is especially prone to ischemia during decreases
in blood pressure. There is also a growing suspicion that immature
white matter might be injured by the systemic inflammatory response
triggered by exposure to bypass. It is the combination of these factors
that might lead to PVL, and this was the basis of our study and why
we decided to study CBF.
Dr Ross M. Ungerleider (Portland, Ore). Certainly The Chil-
dren’s Hospital of Philadelphia, with you and with the addition of
Bill Gaynor and Bill Greeley, who worked with me at Duke for so
many years, is really becoming a leading center in helping us
understand more about cerebral injury in infants.
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DJust listening to your data, it strikes me that you probably could
go back and do a calculation, and I would be interested to hear
whether you have, and that would be cerebral oxygen delivery.
You know what the hematocrit values are of the patients that you
are studying, you know what their blood oxygen levels are, and
now you know the CBF. It would be interesting to know whether
the cerebral oxygen delivery in any way correlated with some ofThe Journal of ThoraciDr Licht. Well, we have collected a lot of data but have not
completed the calculations for oxygen delivery. The placement of
venous and arterial central lines was not dictated by the study
protocol, and therefore not all patients had lines at the time of the
study. Furthermore, the location of the central venous lines needs
to be confirmed by reviewing the chest radiographs performed at
the time of the study to ascertain the accuracy of the mixed venous Cthe findings that you had in terms of neurologic events. measurements. These data will be available soon.c and Cardiovascular Surgery ● Volume 128, Number 6 849
